Intuitive Surgical (NASDAQ: ISRG) reported Q1 EPS of $1.81, $0.07 better than the analyst estimate of $1.74. Revenue for the quarter came in at $2.25 billion versus the consensus estimate of $2.19 billion.

2025 Financial Outlook

The Company expects the following results for the full year of 2025:

• Worldwide da Vinci procedure growth of approximately 15% to 17% in 2025, compared to 17% in 2024.
• Non-GAAP* gross profit margin to be within a range of 65% and 66.5% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 1.7% of revenue, plus or minus 30 basis points.
• Non-GAAP* operating expense growth of 10% to 14% in 2025, compared to 10% in 2024.

For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.